Canada: CADTH Finds Urine Test as Good as Blood for Type II Diabetes Monitoring
The Canadian Agency for Drugs and Technologies in Health (CADTH) Rapid Response Report found in patients with type II diabetes no statistically significant difference between two self-monitoring strategies, urine and blood testing, in glycemic control, measured by HbA1c levels, or in the proportion of patients reaching target HbA1c.
It concluded that findings from large randomized controlled trials comparing benefits of the two monitoring strategies and economic evaluation, such as the on-going DESMOND trial, will help to better understand the implications of self-monitoring of urine glucose in the management of diabetes.
Read more: